Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:dactinomycin
|
| gptkbp:approvedBy |
1964
|
| gptkbp:ATCCode |
L01DA01
|
| gptkbp:CASNumber |
50-76-0
|
| gptkbp:chemicalFormula |
C62H86N12O16
|
| gptkbp:FDAApproved |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cosmegen
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:mechanismOfAction |
inhibits DNA-dependent RNA synthesis
|
| gptkbp:otherName |
gptkb:actinomycin_D
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nausea
vomiting hair loss bone marrow suppression |
| gptkbp:usedFor |
gptkb:Wilms_tumor
gptkb:cancer gptkb:rhabdomyosarcoma gptkb:Ewing_sarcoma gestational trophoblastic neoplasia |
| gptkbp:bfsParent |
gptkb:Recordati
|
| gptkbp:bfsLayer |
7
|